Literature DB >> 2783489

Molecular analysis of a t(14;14) translocation in leukemic T-cells of an ataxia telangiectasia patient.

G Russo1, M Isobe, R Gatti, J Finan, O Batuman, K Huebner, P C Nowell, C M Croce.   

Abstract

We have detected and cloned two rearrangements in the T-cell receptor alpha locus from a clone of somatic cell hybrids carrying a t(14;14)(q11;q32) chromosomal translocation derived from an ataxia telangiectasia patient with T-cell chronic lymphocytic leukemia. The T-cell clone carrying the t(14;14) chromosomal translocation was known to be present for greater than 10 years before the onset of overt leukemia. One molecular rearrangement of the T-cell receptor alpha locus corresponded to a functional variable-joining region (V-J) joining, whereas the other derived from the breakpoint of the t(14;14)(q11;q32) translocation. Chromosomal in situ hybridization of the probe derived from the t(14;14) breakpoint localized the breakpoint region to 14q32.1, apparently the same region that is involved in another ataxia telangiectasia characteristic chromosome translocation, t(7;14)(q35;q32). The 14q32.1 breakpoint is at least 10,000 kilobase pairs (kbp) centromeric to the immunoglobulin heavy chain locus. Sequence analysis of the breakpoint indicates the involvement of a J alpha sequence during the translocation. Comigration of high-molecular weight DNA fragments involved with t(7;14) and t(14;14) translocations suggests the presence of a cluster of breakpoints in the 14q32.1 region, the site of a putative oncogene, TCL1.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2783489      PMCID: PMC286520          DOI: 10.1073/pnas.86.2.602

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Locus of the alpha-chain of the T-cell receptor is split by chromosome translocation in T-cell leukemias.

Authors:  J Erikson; D L Williams; J Finan; P C Nowell; C M Croce
Journal:  Science       Date:  1985-08-23       Impact factor: 47.728

Review 2.  Molecular basis of human B cell neoplasia.

Authors:  C M Croce; P C Nowell
Journal:  Blood       Date:  1985-01       Impact factor: 22.113

3.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

4.  Translocation of immunoglobulin VH genes in Burkitt lymphoma.

Authors:  J Erikson; J Finan; P C Nowell; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

5.  Regulation of the corticosteroid inducibility of tyrosine aminotransferase in interspecific hybrid cells.

Authors:  C M Croce; H Koprowski; G Litwack
Journal:  Nature       Date:  1974-06-28       Impact factor: 49.962

6.  Helper and suppressor t-lymphocyte leukemia in ataxia telangiectasia.

Authors:  A Saxon; R H Stevens; D W Golde
Journal:  N Engl J Med       Date:  1979-03-29       Impact factor: 91.245

7.  Atypical lymphoid leukemia in ataxia telangiectasia.

Authors:  R Levitt; R V Pierre; W L White; R G Siekert
Journal:  Blood       Date:  1978-11       Impact factor: 22.113

8.  Chromosome localization of the gene for human terminal deoxynucleotidyltransferase to region 10q23-q25.

Authors:  M Isobe; K Huebner; J Erikson; R C Peterson; F J Bollum; L M Chang; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

9.  Clonal evolution of T-cell chronic lymphocytic leukaemia in a patient with ataxia telangiectasia.

Authors:  A M Taylor; S V Butterworth
Journal:  Int J Cancer       Date:  1986-04-15       Impact factor: 7.396

10.  Molecular characterization of ataxia telangiectasia T cell clones. II. The clonal inv(14) in ataxia telangiectasia differs from the inv(14) in T cell lymphoma.

Authors:  F Zhang; M H Stern; G Thomas; A Aurias
Journal:  Hum Genet       Date:  1988-04       Impact factor: 4.132

View more
  19 in total

Review 1.  The pathogenesis of ataxia-telangiectasia. Learning from a Rosetta Stone.

Authors:  R A Gatti; S Becker-Catania; H H Chun; X Sun; M Mitui; C H Lai; N Khanlou; M Babaei; R Cheng; C Clark; Y Huo; N C Udar; R K Iyer
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 8.667

Review 2.  New strategies in peripheral T-cell lymphoma: understanding tumor biology and developing novel therapies.

Authors:  Kieron Dunleavy; Richard L Piekarz; Jasmine Zain; John E Janik; Wyndham H Wilson; Owen A O'Connor; Susan E Bates
Journal:  Clin Cancer Res       Date:  2010-12-01       Impact factor: 12.531

Review 3.  Mature T-cell leukemias: Molecular and Clinical Aspects.

Authors:  Nathanael G Bailey; Kojo S J Elenitoba-Johnson
Journal:  Curr Hematol Malig Rep       Date:  2015-12       Impact factor: 3.952

4.  The TCL1 function revisited focusing on metabolic requirements of stemness.

Authors:  Maria Teresa Fiorenza; Alessandro Rava
Journal:  Cell Cycle       Date:  2019-09-29       Impact factor: 4.534

5.  Chromosome walking on the TCL1 locus involved in T-cell neoplasia.

Authors:  L Virgilio; M Isobe; M G Narducci; P Carotenuto; B Camerini; N Kurosawa; C M Croce; G Russo
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

6.  Tcrδ translocations that delete the Bcl11b haploinsufficient tumor suppressor gene promote atm-deficient T cell acute lymphoblastic leukemia.

Authors:  Lori A Ehrlich; Katherine Yang-Iott; Craig H Bassing
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

7.  High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemia.

Authors:  Marco Herling; Kaushali A Patel; Nicole Weit; Nils Lilienthal; Michael Hallek; Michael J Keating; Dan Jones
Journal:  Blood       Date:  2009-09-21       Impact factor: 22.113

8.  ATM-deficient thymic lymphoma is associated with aberrant tcrd rearrangement and gene amplification.

Authors:  Shan Zha; Craig H Bassing; Takaomi Sanda; James W Brush; Harin Patel; Peter H Goff; Michael M Murphy; Suprawee Tepsuporn; Richard A Gatti; A Thomas Look; Frederick W Alt
Journal:  J Exp Med       Date:  2010-06-21       Impact factor: 14.307

9.  High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia.

Authors:  Marco Herling; Kaushali A Patel; Michael A Teitell; Marina Konopleva; Farhad Ravandi; Ryuji Kobayashi; Dan Jones
Journal:  Blood       Date:  2007-09-21       Impact factor: 22.113

10.  De novo microdeletion on an inherited Robertsonian translocation chromosome: a cause for dysmorphism in the apparently balanced translocation carrier.

Authors:  D T Bonthron; S J Smith; J Fantes; C M Gosden
Journal:  Am J Hum Genet       Date:  1993-09       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.